Berberich, A., Keßler, T., Pusch, S., Sahm, F., Schmitt, L., Fischer, M., . . . Wick, W. (2019). Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib. Clinical cancer research, 25(1), . https://doi.org/10.1158/1078-0432.CCR-18-1580
Chicago-Zitierstil (17. Ausg.)Berberich, Anne, et al. "Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib." Clinical Cancer Research 25, no. 1 (2019). https://doi.org/10.1158/1078-0432.CCR-18-1580.
MLA-Zitierstil (9. Ausg.)Berberich, Anne, et al. "Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib." Clinical Cancer Research, vol. 25, no. 1, 2019, https://doi.org/10.1158/1078-0432.CCR-18-1580.